Abstract

CALEJO, Rita et al. COVID-19-induced rhabdomyolysis in an adolescent: A rare presentation. Nascer e Crescer [online]. 2022, vol.31, n.3, pp.317-320.  Epub Sep 30, 2022. ISSN 0872-0754.  https://doi.org/10.25753/birthgrowthmj.v31.i3.27608.

Viral infections are a well-known cause of myositis. The clinical presentation may vary from mild myalgia to severe muscle injury. Coronavirus disease 2019 (COVID-19), a viral respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can be a cause of myositis and of rhabdomyolysis, a rare and severe complication.

A previously healthy 11-year-old female adolescent with COVID-19 presented to the Emergency Department with lower limb pain and inability to walk. The initial laboratory study revealed a marked elevation of muscular enzymes, particularly creatine kinase (13046 UI/L; reference value 149 UI/L). Urine dipstick test reacted positively for hemoglobinuria. The patient started treatment with aggressive intravenous hydration, with progressive clinical and analytical improvement.

Musculoskeletal symptoms associated with COVID-19 are a frequent complaint, with potentially severe complications, such as rhabdomyolysis. A proper and timely diagnosis can prevent further clinical deterioration and enable adequate treatment and follow-up.

Keywords : COVID-19; muscle; myositis; rhabdomyolysis.

        · abstract in Portuguese     · text in English     · English ( pdf )